Total Payments
$1,169
2023 Payments
$47.70
Companies
15
Transactions
45
Medicare Patients
8,920
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$1,054 (90.2%)
Consulting$100.00 (8.6%)
Education$15.00 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,054 | 43 | 90.2% |
| Consulting Fee | $100.00 | 1 | 8.6% |
| Education | $15.00 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $310.06 | 10 | $0 (2019) |
| Sandoz Inc. | $204.80 | 12 | $0 (2019) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $180.30 | 5 | $0 (2023) |
| Sebela Pharmaceuticals Inc. | $116.12 | 5 | $0 (2020) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| Integra LifeSciences Corporation | $57.83 | 3 | $0 (2018) |
| Stryker Corporation | $50.00 | 1 | $0 (2019) |
| Bioventus LLC | $27.77 | 1 | $0 (2019) |
| Smith+Nephew, Inc. | $25.36 | 1 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $20.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $47.70 | 2 | Smith+Nephew, Inc. ($25.36) |
| 2022 | $16.66 | 1 | Ortho Dermatologics, a division of Bausch Health US, LLC ($16.66) |
| 2021 | $22.13 | 1 | Ortho Dermatologics, a division of Bausch Health US, LLC ($22.13) |
| 2020 | $60.36 | 3 | Sebela Pharmaceuticals Inc. ($27.47) |
| 2019 | $521.11 | 17 | Merck Sharp & Dohme Corporation ($181.11) |
| 2018 | $240.34 | 9 | Ortho Dermatologics, a division of Bausch Health US, LLC ($99.31) |
| 2017 | $261.10 | 12 | Merck Sharp & Dohme Corporation ($116.45) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2023 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Other Advanced Wound Management | ||||||
| 02/08/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Podiatry | ||||||
| 04/20/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Podiatry | ||||||
| 12/01/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Podiatry | ||||||
| 12/21/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: PODIATRY | ||||||
| 11/01/2020 | Nabriva Therapeutics, plc | Sivextro (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Oxazolidinone antibiotics | ||||||
| 01/15/2020 | Sebela Pharmaceuticals Inc. | NAFTIN (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: DERMATOLOGY - TOPICAL CORTICOSTEROIDANSTHETIC | ||||||
| 12/19/2019 | Sandoz Inc. | KERYDIN (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/31/2019 | Sebela Pharmaceuticals Inc. | NAFTIN (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: DERMATOLOGY - TOPICAL CORTICOSTEROIDANSTHETIC | ||||||
| 10/29/2019 | Bioventus LLC | Exogen (Device) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Not Applicable | ||||||
| 09/30/2019 | Sebela Pharmaceuticals Inc. | NAFTIN (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: DERMATOLOGY - TOPICAL CORTICOSTEROIDANSTHETIC | ||||||
| 09/25/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/13/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/06/2019 | Sandoz Inc. | KERYDIN (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: DERMATOLOGY | ||||||
| 06/25/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 05/04/2019 | Terumo Medical Corporation | MetaCross (Device) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Lesion Therapy | ||||||
| 04/24/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ANTIBIOTICS | ||||||
| 03/27/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/22/2019 | COMSORT, Inc | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/20/2019 | Sandoz Inc. | KERYDIN (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: DERMATOLOGY | ||||||
| 01/22/2019 | Sandoz Inc. | KERYDIN (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: DERMATOLOGY | ||||||
| 01/10/2019 | Stryker Corporation | SUBFIX (Device) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 12/12/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,199 | 5,490 | $502,809 | $313,692 |
| 2022 | 16 | 2,255 | 5,147 | $470,771 | $300,139 |
| 2021 | 16 | 2,273 | 5,262 | $477,619 | $320,831 |
| 2020 | 16 | 2,193 | 4,565 | $370,580 | $259,474 |
Total Patients
8,920
Total Services
20,464
Medicare Billing
$1.2M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 399 | 1,362 | $146,414 | $105,323 | 71.9% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 747 | 2,348 | $153,845 | $94,341 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 292 | 635 | $88,809 | $52,729 | 59.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 162 | 162 | $23,774 | $15,717 | 66.1% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 113 | 114 | $16,535 | $8,548 | 51.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 77 | 162 | $21,045 | $5,856 | 27.8% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 122 | 162 | $8,122 | $5,788 | 71.3% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2023 | 45 | 48 | $7,212 | $5,176 | 71.8% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 19 | 58 | $7,693 | $5,143 | 66.9% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 32 | 110 | $11,644 | $4,248 | 36.5% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 54 | 79 | $5,912 | $4,133 | 69.9% |
| 11750 | Permanent removal fingernail or toenail | Office | 2023 | 12 | 13 | $2,733 | $1,879 | 68.8% |
| 64455 | Injection of anesthetic and/or steroid drug into foot nerve | Office | 2023 | 14 | 38 | $2,751 | $1,650 | 60.0% |
| 29540 | Placement of strapping to ankle or foot | Office | 2023 | 34 | 65 | $2,419 | $1,503 | 62.2% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 16 | $2,483 | $1,047 | 42.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 64 | 118 | $1,418 | $609.17 | 42.9% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 411 | 1,288 | $135,892 | $101,366 | 74.6% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 829 | 2,383 | $156,087 | $96,545 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 253 | 449 | $60,675 | $37,942 | 62.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 176 | 176 | $24,844 | $18,175 | 73.2% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Office | 2022 | 124 | 124 | $16,824 | $10,117 | 60.1% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2022 | 75 | 82 | $12,235 | $9,123 | 74.6% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 82 | 194 | $24,260 | $7,797 | 32.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 96 | 112 | $7,795 | $3,921 | 50.3% |
| 99347 | Established patient home visit, typically 15 minutes | Office | 2022 | 29 | 74 | $9,293 | $3,451 | 37.1% |
About Dr. Daniel Kormylo, DPM
Dr. Daniel Kormylo, DPM is a Podiatrist healthcare provider based in Rocky Point, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699776674.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kormylo, DPM has received a total of $1,169 in payments from pharmaceutical and medical device companies, with $47.70 received in 2023. These payments were reported across 45 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,054).
As a Medicare-enrolled provider, Kormylo has provided services to 8,920 Medicare beneficiaries, totaling 20,464 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Podiatrist
- Other Specialties Podiatrist
- Location Rocky Point, NY
- Active Since 08/02/2005
- Last Updated 04/03/2024
- Taxonomy Code 213E00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699776674
Products in Payments
- SIVEXTRO (Drug) $410.06
- KERYDIN (Drug) $204.80
- NAFTIN (Drug) $116.12
- LUZU (Drug) $99.31
- JUBLIA (Drug) $80.99
- SUBFIX (Device) $50.00
- OMNIGRAFT (Device) $36.17
- Exogen (Device) $27.77
- GRAFIX PL (Medical Supply) $25.36
- BILAYER WOUND MATRIX BWM (Device) $21.66
- JUBLIA EFINACONAZOLE (Drug) $20.74
- ORBACTIV (Drug) $20.00
- FLEXITOUCH (Device) $16.88
- Baxdela (Drug) $15.09
- Sivextro (Drug) $13.03
- MetaCross (Device) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.